Spyglass Pharma, Inc.
Clinical trials sponsored by Spyglass Pharma, Inc., explained in plain language.
-
Tiny implant could replace daily glaucoma drops for some patients
Disease control Recruiting nowThis study is testing whether a tiny, slow-release implant placed in the eye during cataract surgery works as well as daily prescription eye drops to control eye pressure in people with mild to moderate glaucoma. The implant is designed to release medication continuously over tim…
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Tiny implant could replace daily eye drops for glaucoma
Disease control Recruiting nowThis study is testing if a tiny, slow-release implant placed in the eye during cataract surgery works as well as daily eye drops to lower eye pressure in people with mild to moderate glaucoma. About 400 people who need cataract surgery and have glaucoma will be randomly assigned …
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC